search
Back to results

Prophylaxis of Surgical Wound Infection With Topical Antibiotics

Primary Purpose

Surgical Site Infection, Surgery--Complications, Colorectal Surgery

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Topical antibiotic prophylaxis
Sponsored by
Hospital de Granollers
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Surgical Site Infection focused on measuring Surgical site infection, Prevention, Topical prophylaxis, Wound irrigation, Topical antibiotic prophylaxis, Abdominal surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients admitted for elective abdominal wall surgery by open route
  • Patients admitted for urgent or elective cesarean section
  • Patients undergoing elective surgery of the colon or rectum for neoplastic pathology (open or laparoscopy)
  • Patients undergoing emergency abdominal surgery (open or laparoscopy)

Exclusion Criteria:

  • Patients under treatment with immunosuppressors, corticosteroids and patients on hemodialysis
  • Patients with primary peritonitis and liver cirrhosis
  • Patients with suspected allergy to the antibiotic used in the study
  • Patients who have recently undergone open abdomen surgery (up to 30 days pre-intervention) or to which the wound can not be closed surgical according to the surgeon's criteria
  • Patients with American Society of Anaesthesiology classification 5.

Sites / Locations

  • Fundació Privada Hospital Asil de GranollersRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

In the experimental arm, the surgical wound will be irrigated using an antibiotic solution (amoxicillin-clavulanate) for topical prophylaxis

In the control arm, the surgical wound will be irrigated with saline, which is our routine at present.

Outcomes

Primary Outcome Measures

Surgical Site infection rate
signs of infection at any level of surgical site

Secondary Outcome Measures

Complications after surgery
Any complication after surgery, evaluated by the Clavien-dindo classification

Full Information

First Posted
January 31, 2019
Last Updated
April 12, 2023
Sponsor
Hospital de Granollers
search

1. Study Identification

Unique Protocol Identification Number
NCT04476212
Brief Title
Prophylaxis of Surgical Wound Infection With Topical Antibiotics
Official Title
Prophylaxis of Surgical Wound Infection With Topical Antibiotics
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 27, 2018 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital de Granollers

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Surgical site infection (SSI) is the main complication of surgery. The prevention of superficial SSI by topical prophylaxis is controversial. Human studies on wound lavage with topical solutions (saline, antiseptics or antibiotics) are old and do not yield conclusive results. In experimental conditions there is evidence in favor of the efficiency wound lavage with saline and antibiotic solutions. Clinical studies are needed to demonstrate the safety and efficacy of antibiotic lavage. Objective. Study of the efficacy of topical antibiotic therapy in the prevention of SSI in patients undergoing abdominal surgery with different risk of infection. Method. Project comprising several randomized double-blind clinical trials with a common methodology. Procedures with varying degrees of contamination, as emergency abdominal surgery, cesareans and complex abdominal wall reconstructions will be studied. Follow-up will be 30 days after operation. Data will be collected anonymously and the relationships between the variables will be analyzed using Pearson's chi-square, survival analysis and analysis of risk factors as appropriate. The effect of topical antibiotic on hospital stay, resistance patterns in SSI, and antibiotic serum levels will be analyzed.
Detailed Description
Several Surgical site infection (SSI) prevention guidelines have been published over the last 10 years. Topical prophylaxis of the surgical wound with antibiotics or antiseptics is one of the most controversial measures proposed for SSI prevention. Two guidelines (British, Spanish Ministry of Health) explicitly recommend not irrigating surgical wounds with any product. The World Health Organization considers irrigation with antibiotics as an unresolved issue and, together with the Centers for Disease Control, recommends irrigation with a solution of povidone iodine. The other four guides do not mention the measure. In Catalonia, a SSI prevention bundle recommends wound irrigation with saline, with a low level of recommendation. Therefore, topical prophylaxis with operational wound washings with different solutions has been poorly studied, evokes contradictory recommendations and is not included in the majority of clinical practice guidelines for SSI prevention. However, there we detected a high level of use of wound irrigation at the end of an intervention in actual clinical practice. In a survey conducted by 2017 by our group and answered by 845 general surgeons of the Spanish Association of Surgeons, before closing the skin, most surgeons (80.6%) irrigate the subcutaneous layer of the wound, either with saline (51.2%), an antiseptic solution (23.8%) or an antibiotic solution (1.5%). Only 19.4% of respondents do not irrigate. In another survey in 2018, focused on colorectal surgeons of two Spanish associations, similar rates of irrigation with saline, antiseptic or antibiotic were used (55%, 28.9% and 2.2%, respectively) The hypothesis of the study is that topical prophylaxis of the surgical wound with irrigation with an antibiotic solution decreases the rate of postoperative infection in patients undergoing abdominal surgery with different levels of contamination. The study will compare the efficacy of topical prophylaxis in the surgical wound with an irrigation with an antibiotic solution in the incidence of SSI in abdominal surgery. It is a randomized, controlled, multicenter, blind study by observer and patient, with two parallel study groups, phase IV. Design of studies The project includes several prospective comparative studies on the effect of irrigation of surgical wounds with an antibiotic solution on the incisional SSI rate in abdominal surgery. The studies share a unique methodology applied to various types of abdominal surgery with different expected SSI rates and different risk factors. In the trials, the irrigation of the wound with 0.9% physiological serum will be compared with the irrigation with an active principle solution of a pharmaceutical specialty of proven efficacy by parenteral route, administered topically and dissolved in physiological serum. Four studies on different types of operations are defined according to the risk of infection: Study 1. Complex abdominal wall surgery Study 2. Cesarean section Study 3. Colorectal elective surgery Study 4. Emergency abdominal surgery For each study two groups will be formed, the study group (irrigation with antibiotic solution) and the control group (irrigation with saline). The project has received the Spanish Drug Agency authorization as a low intervention study, a grant from the Spanish Ministry of Health and the Ethics Committee authorization of the Hospital General of Granollers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Site Infection, Surgery--Complications, Colorectal Surgery, Cesarean Section; Infection, Hernia, Abdominal
Keywords
Surgical site infection, Prevention, Topical prophylaxis, Wound irrigation, Topical antibiotic prophylaxis, Abdominal surgery

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
It is a randomized, controlled, multicenter, blind study by observer and patient, with two parallel study groups, phase IV. The irrigation of the wound with 0.9% physiological serum will be compared with the irrigation with a solution of amoxicillin-clavulanate, administered topically and dissolved in saline.
Masking
ParticipantCare ProviderInvestigator
Masking Description
There will be masking for the patient, for the surgeon responsible for the case, for the investigator responsible for each study, for the coordinator of the center and for the main investigator. After the closure of the abdominal fascia, the patients will be randomized to one of the study groups. The circulating nurse will open the randomization envelope and prepare the solution indicated on the outside of the operating room. He/she will record the case on the database and will be the only person with knowledge of the group allocation of the case.
Allocation
Randomized
Enrollment
560 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
In the experimental arm, the surgical wound will be irrigated using an antibiotic solution (amoxicillin-clavulanate) for topical prophylaxis
Arm Title
Control
Arm Type
No Intervention
Arm Description
In the control arm, the surgical wound will be irrigated with saline, which is our routine at present.
Intervention Type
Other
Intervention Name(s)
Topical antibiotic prophylaxis
Intervention Description
The surgical wound will be irrigated with an antibiotic solution, and then we will apply the same solution using gauze for two minutes on the wound
Primary Outcome Measure Information:
Title
Surgical Site infection rate
Description
signs of infection at any level of surgical site
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Complications after surgery
Description
Any complication after surgery, evaluated by the Clavien-dindo classification
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients admitted for elective abdominal wall surgery by open route Patients admitted for urgent or elective cesarean section Patients undergoing elective surgery of the colon or rectum for neoplastic pathology (open or laparoscopy) Patients undergoing emergency abdominal surgery (open or laparoscopy) Exclusion Criteria: Patients under treatment with immunosuppressors, corticosteroids and patients on hemodialysis Patients with primary peritonitis and liver cirrhosis Patients with suspected allergy to the antibiotic used in the study Patients who have recently undergone open abdomen surgery (up to 30 days pre-intervention) or to which the wound can not be closed surgical according to the surgeon's criteria Patients with American Society of Anaesthesiology classification 5.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Josep Maria Badia, PhD
Phone
(+34) 938 425 000
Ext
2571
Email
jmbadia@fhag.es
First Name & Middle Initial & Last Name or Official Title & Degree
Gemma Molist, PhD
Phone
(+34) 938 425 000
Ext
2973
Email
recerca@fjah.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Josep Maria Badia, PhD
Organizational Affiliation
Fundació Privada Hospital Asil de Granollers
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Felipe Ojeda, PhD
Organizational Affiliation
Fundació Privada Hospital Asil de Granollers
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fundació Privada Hospital Asil de Granollers
City
Granollers
State/Province
Barcelona
ZIP/Postal Code
08402
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Josep Maria Badia, PhD
Phone
(+34) 938 425 000
Ext
2571
Email
jmbadia@fhag.es
First Name & Middle Initial & Last Name & Degree
Gemma Molist, PhD
Phone
(+34) 938 425 000
Ext
2973
Email
recerca@fhag.es
First Name & Middle Initial & Last Name & Degree
Josep Maria Badia, PhD
First Name & Middle Initial & Last Name & Degree
Felipe Ojeda, PhD

12. IPD Sharing Statement

Learn more about this trial

Prophylaxis of Surgical Wound Infection With Topical Antibiotics

We'll reach out to this number within 24 hrs